Pharmaxis Ltd (AU:SNT) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Pharmaxis Ltd has announced a significant increase in the options held by Director Gary Jonathan Phillips, under the Syntara Employee Option Plan. Following shareholder approval, Phillips’ direct options have risen from 6,845,800 to 9,616,800, reflecting a strategic move within the company. This development may intrigue investors tracking executive actions within Pharmaxis Ltd.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
